Michael Epstein

Michael Epstein, MS, is an experienced regulatory operations leader with over 20 years of expertise in the pharmaceutical and biotech industries. They currently serve as the Head of Regulatory Operations and Submission Management at Cytokinetics and previously held the role of Vice President, Regulatory Operations and Submission Management at Reata Pharmaceuticals, where they led a team overseeing submission planning and regulatory strategy. Michael has also held notable positions at Acadia Pharmaceuticals, Ardea Biosciences, and Allergan, managing regulatory project management teams and driving improvements in regulatory information systems. They earned a Master of Science in Regulatory Science from the University of Southern California.